Erythrabyssin ll is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer.
- DOI
- 10.1016/j.isci.2025.112801
- Published
- 2025 Jul 18
- Container
- iScience
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.isci.2025.112801,
title = {Erythrabyssin ll is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer.},
author = {Mo J and Cai Q and Chen S and Luo J and Hu Z and Su L and Cheng L and Huang L and Liu S and Wang X and Liu Q and Chen L and Mao S and Sun Y},
year = {2025},
journal = {iScience},
doi = {10.1016/j.isci.2025.112801},
url = {https://doi.org/10.1016/j.isci.2025.112801}
}RIS
TY - JOUR TI - Erythrabyssin ll is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer. AU - Mo J AU - Cai Q AU - Chen S AU - Luo J AU - Hu Z AU - Su L AU - Cheng L AU - Huang L AU - Liu S AU - Wang X AU - Liu Q AU - Chen L AU - Mao S AU - Sun Y PY - 2025 JO - iScience DO - 10.1016/j.isci.2025.112801 UR - https://doi.org/10.1016/j.isci.2025.112801 ER -
APA
J, M., Q, C., S, C., J, L., Z, H., L, S., L, C., L, H., S, L., X, W., Q, L., L, C., S, M., & Y, S. (2025). Erythrabyssin ll is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer.. iScience. https://doi.org/10.1016/j.isci.2025.112801
Source records
- pubmed · retrieved 2026-09-25T23:51:46.059Z